BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26719134)

  • 1. Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities.
    Pasquel FJ; Hendrick AM; Ryan M; Cason E; Ali MK; Narayan KM
    J Diabetes Sci Technol; 2015 Dec; 10(2):301-7. PubMed ID: 26719134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
    Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
    Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
    Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
    Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
    Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
    Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.
    Sharafeldin N; Kawaguchi A; Sundaram A; Campbell S; Rudnisky C; Weis E; Tennant MTS; Damji KF
    Br J Ophthalmol; 2018 Nov; 102(11):1485-1491. PubMed ID: 29680803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and Next Generation Portable Screening Devices for Diabetic Retinopathy.
    Micheletti JM; Hendrick AM; Khan FN; Ziemer DC; Pasquel FJ
    J Diabetes Sci Technol; 2016 Feb; 10(2):295-300. PubMed ID: 26888973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of teleretinal screening for diabetic retinopathy in a county hospital population.
    Phan AD; Koczman JJ; Yung CW; Pernic AA; Doerr ED; Kaehr MM
    Diabetes Care; 2014 Dec; 37(12):e252-3. PubMed ID: 25414394
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year experience of tele-ophthalmology for diabetic retinopathy screening in a rural population.
    Rodríguez Villa S; Alonso Álvarez C; de Dios Del Valle R; Salazar Méndez R; Cuesta García M; Ruiz García MJ; Cubillas Martín M; Rodríguez Vazquez M
    Arch Soc Esp Oftalmol; 2016 Sep; 91(9):426-30. PubMed ID: 26900042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy screening: a systematic review of the economic evidence.
    Jones S; Edwards RT
    Diabet Med; 2010 Mar; 27(3):249-56. PubMed ID: 20536486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DrishtiCare: a telescreening platform for diabetic retinopathy powered with fundus image analysis.
    Joshi GD; Sivaswamy J
    J Diabetes Sci Technol; 2011 Jan; 5(1):23-31. PubMed ID: 21303621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
    Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S15-S18. PubMed ID: 29074007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should We Add Screening of Age-Related Macular Degeneration to Current Screening Programs for Diabetic Retinopathy?
    Chew EY; Schachat AP
    Ophthalmology; 2015 Nov; 122(11):2155-6. PubMed ID: 26498078
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for Telemedicine for Diabetic Retinal Disease.
    Gupta A; Cavallerano J; Sun JK; Silva PS
    Semin Ophthalmol; 2017; 32(1):22-28. PubMed ID: 27748634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diabetic Retinopathy Screening Workflow: Potential for Smartphone Imaging.
    Bolster NM; Giardini ME; Bastawrous A
    J Diabetes Sci Technol; 2015 Nov; 10(2):318-24. PubMed ID: 26596630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Utility Analysis of Screening Strategies for Diabetic Retinopathy in Korea.
    Kim SW; Kang GW
    J Korean Med Sci; 2015 Dec; 30(12):1723-32. PubMed ID: 26713046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Implementation of Teleretinal Diabetic Retinopathy Screening Programs Across the University of California.
    Chen JS; Lin MC; Yiu G; Thorne C; Kulasa K; Stewart J; Nudleman E; Freeby M; Han MA; Baxter SL
    Telemed J E Health; 2023 Dec; 29(12):1810-1818. PubMed ID: 37256712
    [No Abstract]   [Full Text] [Related]  

  • 20. Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.
    Liu Y; Torres Diaz A; Benkert R
    Curr Diab Rep; 2019 Aug; 19(9):74. PubMed ID: 31375932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.